China Resources Pharma Arm Expects Up to 50% Higher Attributable Profit in Nine Months to September

MT Newswires Live10-09

China Resources Pharmaceutical Group's (HKG:3320) subsidiary Dong-E-E-Jiao expects to record a profit attributable to its shareholders between 1.10 billion yuan and 1.18 billion yuan for the nine months ended Sept. 30, 40% to 50% higher than 783.7 million yuan logged for the same period last year, a Wednesday filing with the Hong Kong Exchange said.

The company attributed the increase in profit to Dong-E-E-Jiao's consumer-centered approach, integrating marketing with digital placement and adoption of a "dual-wheel drive" growth model.

The pharmaceutical and healthcare products company's shares closed nearly 4% lower on Wednesday.

Price (HKD): $5.93, Change: $-0.22, Percent Change: -3.58%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2474246691?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-09 19:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474246691","market":"us","top_or_hot":-1,"title":"China Resources Pharma Arm Expects Up to 50% Higher Attributable Profit in Nine Months to September","media":"MT Newswires Live","content":"<html><body><p> China Resources Pharmaceutical Group's (HKG:3320) subsidiary Dong-E-E-Jiao expects to record a profit attributable to its shareholders between 1.10 billion yuan and 1.18 billion yuan for the nine months ended Sept. 30, 40% to 50% higher than 783.7 million yuan logged for the same period last year, a Wednesday filing with the Hong Kong Exchange said.</p><p>The company attributed the increase in profit to Dong-E-E-Jiao's consumer-centered approach, integrating marketing with digital placement and adoption of a \"dual-wheel drive\" growth model.</p><p>The pharmaceutical and healthcare products company's shares closed nearly 4% lower on Wednesday.</p><p>Price (HKD): $5.93, Change: $-0.22, Percent Change: -3.58%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Resources Pharma Arm Expects Up to 50% Higher Attributable Profit in Nine Months to September</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Resources Pharma Arm Expects Up to 50% Higher Attributable Profit in Nine Months to September\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-09 19:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>China Resources Pharmaceutical Group's (HKG:3320) subsidiary Dong-E-E-Jiao expects to record a profit attributable to its shareholders between 1.10 billion yuan and 1.18 billion yuan for the nine ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2474246691","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474246691","pubTimestamp":1728473646,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"China Resources Pharmaceutical Group's  subsidiary Dong-E-E-Jiao expects to record a profit attributable to its shareholders between 1.10 billion yuan and 1.18 billion yuan for the nine months ended Sept. 30, 40% to 50% higher than 783.7 million yuan logged for the same period last year, a Wednesday filing with the Hong Kong Exchange said.The company attributed the increase in profit to Dong-E-E-Jiao's consumer-centered approach, integrating marketing with digital placement and adoption of a \"dual-wheel drive\" growth model.The pharmaceutical and healthcare products company's shares closed nearly 4% lower on Wednesday.Price : $5.93, Change: $-0.22, Percent Change: -3.58%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4141":"半导体产品","BK4023":"应用软件","BK4526":"热门中概股","IE00BMPRXR70.SGD":"Neuberger Berman 5G Connectivity A Acc SGD-H","BK1570":"华润系","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","03320":"华润医药","BK4585":"ETF&股票定投概念","IE00BMPRXQ63.HKD":"NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY FUND \"A\" (HKDHDG) ACC","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","BK1191":"制药","09922":"九毛九"},"translate_title":"华润医药部门预计截至9月的9个月归属利润将增长50%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":0.9,"09922":0.6},"content_text":"China Resources Pharmaceutical Group's (HKG:3320) subsidiary Dong-E-E-Jiao expects to record a profit attributable to its shareholders between 1.10 billion yuan and 1.18 billion yuan for the nine months ended Sept. 30, 40% to 50% higher than 783.7 million yuan logged for the same period last year, a Wednesday filing with the Hong Kong Exchange said.The company attributed the increase in profit to Dong-E-E-Jiao's consumer-centered approach, integrating marketing with digital placement and adoption of a \"dual-wheel drive\" growth model.The pharmaceutical and healthcare products company's shares closed nearly 4% lower on Wednesday.Price (HKD): $5.93, Change: $-0.22, Percent Change: -3.58%","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2474246691"}